Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)

被引：0
|
作者：
van Son, Koen C. [1 ,2 ,3 ]
van Dijk, Anne-Marieke [1 ,2 ]
Driessen, Stan [1 ,2 ]
Mak, Anne Linde [1 ]
Witjes, Julia J. [1 ]
Houttu, Veera A. T. [1 ]
Zwirs, Diona [1 ]
Nieuwdorp, Max [1 ]
van den Born, Bert-Jan H. [1 ,4 ]
Fischer, Johan C. [5 ]
Tushuizen, Maarten E. [6 ]
Drenth, Joost P. H. [3 ]
Hamer, Henrike M. [5 ]
Beuers, Ulrich H. W. [3 ]
Verheij, Joanne [2 ,7 ]
Holleboom, Adriaan Georgius [1 ]
机构：
[1] Amsterdam UMC, Locat AMC, Dept Vasc Med, Meibergdreef 9, Amsterdam, Netherlands
[2] Amsterdam Gastroenterol Endocrinol Metab AGEM Inst, Amsterdam UMC, Locat AMC, Amsterdam, Netherlands
[3] Amsterdam UMC, Dept Gastroenterol & Hepatol, Locat AMC, Meibergdreef 9, Amsterdam, Netherlands
[4] Dept Publ & Occupat Hlth, Amsterdam UMC, Locat AMC, Amsterdam, Netherlands
[5] Univ Amsterdam, Dept Lab Med, Lab Specialized Diagnost & Res, Amsterdam UMC, Amsterdam, Netherlands
[6] Dept Gastroenterol & Hepatol, LUMC, Leiden, Netherlands
[7] Amsterdam UMC, Locat AMC, Dept Pathol, Amsterdam, Netherlands
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2024年 / 62卷 / 11期
关键词：
metabolic dysfunction-associated steatotic liver disease (MASLD); advanced liver fibrosis; enhanced liver fibrosis (ELF)-test; reflex testing; diagnostic algorithms;
D O I：
10.1515/cclm-2024-0470
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：e236 / e239
页数：4
相关论文
共 50 条
  • [21] Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
    Chan, Wah-Kheong
    Chuah, Kee-Huat
    Rajaram, Ruveena Bhavani
    Lim, Lee-Ling
    Ratnasingam, Jeyakantha
    Vethakkan, Shireene Ratna
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2023, 32 (03) : 197 - 213
  • [22] EATING DISORDERS IN MEXICAN POPULATION WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Contreras, Ana D. Cano
    Alvarez, Hector Ricardo Ordaz
    Priego-Parra, Bryan Adrian
    Martinez-Perez, Genesis Patricia
    Reyes-Diaz, Sara A.
    Azamar, Pamela Duran
    Garcia-Carvajal, Mario J.
    Diaz-Crespo, Angel H.
    Vazquez-Cruz, Anette P.
    Hernandez, Tonatiu Castellanos
    Basurto, Jose Luis Vargas
    Dietlen, Federico B. Roesch
    Francisco, Maria D.
    Amieva-Balmori, Mercedes
    Remes-Troche, Jose Maria
    GASTROENTEROLOGY, 2024, 166 (05) : S1649 - S1650
  • [23] ALTERED GUT VIRAL ECOLOGY IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Nzabarushimana, Etienne
    Kim, Hanseul
    Jensen, Jordan
    Shen, Jiaxian
    Nelson, Paul
    Thompson, Kelsey N.
    Chan, Andrew T.
    Hayete, Boris
    Huttenhower, Curtis
    Nguyen, Long H.
    GASTROENTEROLOGY, 2024, 166 (05) : S1539 - S1540
  • [24] Evaluation of a Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Clinical Pharmacy Service
    Sallam, Sandy
    Ahmed, Aijaz
    Gu, Xin
    DIABETES, 2024, 73
  • [25] Exploring Autoantibodies as Predictors of Severe Fibrosis or Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Response
    Faisal, Nabiha
    Minuk, Gerald
    CANADIAN LIVER JOURNAL, 2024, 7 (04): : 417 - 418
  • [26] Real world evaluation of a primary care pathway for the assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD)
    Ahmad, Basil
    Mitchell, Oliver
    Pannifex, Sally
    Singanayagam, Arjuna
    Hughes, Sarah
    Clark, Sarah
    Yalcin, Metin
    Williams, Nicola
    Davie, Sarah
    Forton, Daniel
    JOURNAL OF HEPATOLOGY, 2024, 80 : S523 - S523
  • [27] Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD)
    Wong, Robert J.
    METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (04):
  • [28] Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
    Nakamura, Toru
    Masuda, Atsutaka
    Nakano, Dan
    Amano, Keisuke
    Sano, Tomoya
    Nakano, Masahito
    Kawaguchi, Takumi
    CELLS, 2025, 14 (06)
  • [29] Assessing the diagnostic accuracy of ChatGPT-4 in the histopathological evaluation of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD)
    Akpinar, Reha
    Laohawetwanit, Thiyaphat
    Panzeri, Davide
    De Carlo, Camilla
    Belsito, Vincenzo
    Terracciano, Luigi
    Aghemo, Alessio
    Pugliese, Nicola
    Calderaro, Julien
    Sironi, Laura
    Di Tommaso, Luca
    JOURNAL OF HEPATOLOGY, 2024, 80 : S580 - S580
  • [30] SUBOPTIMAL ASSESSMENT OF FIBROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN PRIMARY CARE VERSUS LIVER CLINIC SETTINGS
    Nguyen, Brian T.
    Nguyen, Vy H.
    Park, Jung Eun
    Gudapati, Surya T.
    Maeda, Mayumi
    Kam, Leslie Y.
    Cheung, Ramsey
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2024, 166 (05) : S1651 - S1652
12345